What contrast agent should be used for a micturating cystourethrogram (MCU) and retrograde urethrogram (RGU)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Contrast Agent for MCU and RGU

Use water-soluble iodinated contrast material for both micturating cystourethrogram (MCU) and retrograde urethrogram (RGU). This is the standard contrast agent specified across multiple authoritative guidelines for these fluoroscopic procedures 1, 2, 3, 1.

Specific Technical Details

For MCU (Voiding Cystourethrography/VCUG)

  • Contrast type: Dilute water-soluble iodinated contrast material 1
  • Administration: Retrograde gravity filling through urethral catheter
  • Volume: Minimum 300 mL or until patient reaches tolerance to achieve maximal bladder distention 1
  • Temperature: Use body temperature ("warm") contrast rather than room temperature 4
    • Warm contrast causes significantly less patient distress (p<0.05)
    • Does not prolong screening time or increase contrast volume required
    • May demonstrate vesicoureteric reflux more frequently (16% vs 6%, though not statistically significant)

For RGU (Retrograde Urethrography)

  • Contrast type: Water-soluble iodinated contrast material 1, 2, 3
  • Administration: Retrograde instillation via urethral meatus
  • Indication: Mandatory before catheter placement in patients with blood at urethral meatus, especially with pelvic fractures or straddle injury 3

Critical Technical Considerations

Do not simply clamp a Foley catheter and allow IV-administered contrast to accumulate - this technique provides inadequate bladder distention and results in missed bladder injuries 1. Active retrograde filling is required for diagnostic accuracy.

For CT cystography (an alternative to fluoroscopic cystography), use dilute water-soluble iodinated contrast to prevent artifacts from obscuring visualization 1, 3, 1.

Special Populations

Patients with Prior Contrast Reactions

If the patient has a history of reaction to IV contrast media:

  • Reconsider the need for fluoroscopic MCU
  • Consider nuclear medicine cystography as an alternative
  • If fluoroscopic MCU is necessary, use nonionic contrast media with steroid premedication and perform in hospital setting 5

Pediatric Patients

The same water-soluble iodinated contrast is used in children 3, 6. Alternative modalities include:

  • Voiding urosonography (VUS) using ultrasound microbubble contrast (SonoVue) - sensitivity 92.3%, specificity 98.3% compared to MCU 7
  • Nuclear medicine cystography for follow-up studies 6

Contrast Safety Profile

Iodinated contrast used for MCU/RGU has minimal systemic absorption through intact bladder mucosa, though adverse reactions can occur 5. The bladder mucosa shows dehydration and hydropic changes that may persist up to 3 months, but no inflammatory changes occur 8. Appropriate resuscitation facilities must be available during these procedures 5.

Avoid using gadolinium-based contrast agents - these are not indicated for MCU or RGU and are reserved for MRI studies with specific renal failure considerations 9.

References

Guideline

urotrauma: aua guideline.

The Journal of urology, 2014

Guideline

kidney and uro-trauma: wses-aast guidelines.

World Journal of Emergency Surgery, 2019

Guideline

acr appropriateness criteria<sup>®</sup> hematuria-child.

Journal of the American College of Radiology, 2018

Guideline

acr appropriateness criteria® urinary tract infection-child: 2023 update.

Journal of the American College of Radiology, 2024

Guideline

acr appropriateness criteria® renal failure.

Journal of the American College of Radiology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.